Skip to main content

Day: June 24, 2022

Pliant Therapeutics Announces Presentations at the International Liver Congress™ 2022 Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial

SOUTH SAN FRANCISCO, Calif., June 24, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the presentation of two scientific posters at the International Liver Congress™ (ILC) 2022 of the European Association for the Study of the Liver (EASL), taking place June 22-26, 2022, in London, United Kingdom. “Our presentations at this year’s International Liver Congress summarize the translational research findings supporting the hepatic antifibrotic activity of PLN-74809, an oral dual αvß6 / αvß1 integrin inhibitor,” said Éric Lefebvre, M.D., Chief Medical Offer at Pliant Therapeutics. “Preliminary safety data from the INTEGRIS-PSC study continue to show a favorable tolerability profile...

Continue reading

Quotient Limited Announces Pricing of Underwritten Offering

JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) — Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 66,666,667 ordinary shares and ordinary share equivalents for aggregate gross proceeds of $20.0 million. The aggregate net proceeds to the Company from this offering are expected to be approximately $18.5 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. All of the securities sold in the offering were offered by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 10,000,000 of its ordinary shares. The offering is expected to close on June 28th, 2022, subject to customary closing conditions. The...

Continue reading

Notification of Executive’s transaction with Matas shares

Company announcement no. 06 2022/23 Allerød, 24 June 2022In accordance to the EU Market Abuse Regulation Article 19 no. 596/2014, Matas has received the following notification from Executives and/or their related parties’ regarding transactions in Matas shares.Contact Frederikke Linde Head of Investor Relations, tel. +45 60 62 60 87Attachment06 Notification of Executive’s transaction with Matas shares UK

Continue reading

Guardforce AI Announces Closing of Previously Announced Acquisition of Beijing Wanjia Security System Co., Ltd

The Acquisition Strengthens Guardforce AI’s Integrated Security Solutions in China NEW YORK, NY , June 24, 2022 (GLOBE NEWSWIRE) — Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ:GFAI,GFAIW), an integrated security solutions provider, announced today that it has acquired Beijing Wanjia Security System Co., Ltd. (“BJWJ”) from Shenzhen Yeantec Co., Limited (“Yeantec”) for approximately US $8.4 million. BJWJ is an integrated alarm security solution provider with more than 25 years of experience and a well-established customer base among retail businesses. The acquisition was paid for in a combination of cash (10%) and restricted ordinary shares of the Company (90%) at the previously agreed price of U.S. $2.00 per share. As previously announced, on May 24, 2022, Guardforce AI entered into two definitive...

Continue reading

KANZHUN LIMITED Announces First Quarter 2022 Financial Results

BEIJING, June 24, 2022 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ), a leading online recruitment platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2022. First Quarter 2022 Highlights • Revenues for the first quarter of 2022 were RMB1,137.9 million (US$179.5 million), an increase of 44.3% from RMB788.5 million for the same quarter of 2021. • Calculated cash billings1 for the first quarter of 2022 were RMB1,291.5 million (US$203.7 million), an increase of 9.2% from RMB1,182.4 million for the same quarter of 2021. • Average monthly active users2 for the first quarter of 2022 were 25.2 million, compared to 24.9 million for the same quarter of 2021. • Total paid enterprise customers3 in the twelve months ended March 31, 2022 increased by 41.4%...

Continue reading

Quotient Limited Provides Fourth Quarter Fiscal 2022 Results and Business Update

Financial PositionAmended Secured Notes: Reduces the company’s cash obligations by approximately $93 million over the next 36 months Announces Public Equity Offering: Improving liquidity runway FY 2022 Revenue of $38.5 Million $83.2 million in cash and investments as of March 31, 2022 MosaiQ™ SolutionCommercial Execution:Extended IH Launch: Commercialization is underway; $1.4 million of MosaiQ orders in Q1 FY2023; Multiple MosaiQ instruments shipped to customers Tenders: Actively engaged in Immunohematology (IH) donor tenders; 20 European IH donor tender submissions expected in the next 18 months Distribution Network: 9 international agreements in place and expanding global distribution network Transfusion Diagnostics: Extended Serological Disease Screening (SDS) microarray panel continues to progress towards EU commercial...

Continue reading

K92 Mining Announces Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend K92 Shareholders Vote FOR All Proposed Items at the Upcoming Annual General Meeting

How to Vote – Shareholder Information and Questions How to Vote – Shareholder Information and QuestionsVANCOUVER, British Columbia, June 24, 2022 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT, OTCQX: KNTNF ) is pleased to announce that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co. (“Glass Lewis”) have each recommended K92 shareholders (“K92 Shareholders”) vote “FOR” all the proposed resolutions at the upcoming Annual General Meeting of Shareholders (the “Meeting”). ISS and Glass Lewis are two leading independent, third party proxy advisory firms who, among other services, provide proxy-voting recommendations to pension funds, investment managers, mutual funds and other institutional shareholders. The Board of Directors...

Continue reading

Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate

GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted). AV7909 is the company’s new anthrax vaccine candidate evaluated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. The Prescription Drug User Fee Act goal date for a decision by the FDA is in April 2023. “Over the last 20 years, Emergent has partnered with the U.S. government to lead this program from early- to advanced-stage development,” said Kelly Warfield, senior vice president research and development...

Continue reading

Caisse Française de Financement Local: EMTN 2022-9

Issy les Moulineaux, 24 June 2022 Caisse Française de Financement Local has decided to issue on 28 June 2022 – EUR 100,000,000 Fixed Rate Obligations Foncières  due 28 June 2032. The Base Prospectus dated 10 June 2022 relating to the Euro Medium Term Notes Programme approved by the Autorité des Marchés Financiers is available on the website of the issuer (www.caissefrancaisedefinancementlocal.fr), at the registered office of the issuer: 1-3 rue du Passeur de Boulogne – 92130 Issy Les Moulineaux Cedex, France, and at the office of the paying agent indicated in the Base Prospectus. The Final Terms relating to the issue will be available on the website of the AMF (www.amf-france.org) and the Luxembourg Stock Exchange (www.bourse.lu), at the office of the issuer and at the office of the paying agent.AttachmentCommuniqué...

Continue reading

Breytingar á stórnendateymi PLAY samhliða auknum umsvifum

Breytingar á stórnendateymi PLAY samhliða auknum umsvifum Sonja Arnórsdóttir hefur verið ráðin framkvæmdastjóri sölu- og markaðssviðs PLAY. Sonja tekur við sem framkvæmdastjóri sviðsins af Georgi Haraldssyni sem verður framkvæmdastjóri upplýsingatæknisviðs. Sonja er með BS-gráðu í fjármálaverkfræði og hefur starfað við tekjustýringu hjá flugfélögum síðastliðin tíu ár. Hún starfaði sem sérfræðingur í tekjustýringu hjá WOW air þar sem hún leiddi tíu manna teymi og þá hefur hún starfað sem forstöðumaður tekjustýringar- og sölu hjá PLAY frá 2019. Sonja mun nú bera ábyrgð á öllum sölu- og markaðsmálum hjá PLAY. „Ég er virkilega spennt og ánægð með það tækifæri að fá að stýra öflugu sölu- og markaðsteymi PLAY. Síðustu tíu ár hef ég komið að uppbyggingu tveggja flugfélaga á Íslandi og tekist á við margvísleg krefjandi verkefni sem fylgja þessum...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.